US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cardiovascular Systems, Inc. - Common Stock
(NQ:
CSII
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cardiovascular Systems, Inc. - Common Stock
< Previous
1
2
Next >
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial
April 03, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII
March 29, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
February 22, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
February 14, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII
February 13, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Cardiovascular Systems (NASDAQ: CSII) Enters Into Agreement to be Acquired By Abbott Labs (NYSE: ABT) For $890 Million
February 09, 2023
Cardiovascular Systems, Inc. (NASDAQ: CSII) is engaged as a medical device company, which is focused on the research, development and
Via
Spotlight Growth
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
February 09, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
CSII STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Cardiovascular Systems, Inc. Is Fair to Shareholders
February 09, 2023
From
Halper Sadeh LLC
Via
Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2023 Second Quarter Financial Results
February 08, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023
January 19, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study
January 11, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
January 04, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences
November 09, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
November 03, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
October 17, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
October 12, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
August 02, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
July 13, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results
May 04, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. to Host Earnings Conference Call on May 4, 2022
April 13, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences
March 22, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Announces First In-Human Experience With Company’s Propel™ Percutaneous Ventricular Assist Device
March 16, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices
February 23, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results
February 03, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. to Participate at SVB Leerink 2022 Global Healthcare Conference
January 27, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon
January 20, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases
January 13, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
CORRECTING and REPLACING Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
January 06, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
January 06, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2022 First Quarter Financial Results
November 09, 2021
From
Cardiovascular Systems, Inc.
Via
Business Wire
< Previous
1
2
Next >
